Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: sylvester80 who wrote (1261771)	9/14/2020 12:08:09 AM
From: Winfastorlose	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1576711

President Trump presents the Medal of Honor to Sergeant Major Thomas Payne, the first living Delta Force member to receive the award. Payne helped rescue 75 hostages in Iraq from ISIS — 20 terrorists were killed.

To: sylvester80 who wrote (1261771)	9/14/2020 12:16:39 AM
From: Winfastorlose	1 Recommendation Recommended By Mick Mørmøny Read Replies (1) \| Respond to of 1576711

Trump issues executive order to lower Medicare drug prices for seniors Order's 'most-favored-nation price' ties Medicare costs to those paid in other countries. Drugmakers outraged. Trump's approach is strongly opposed by the pharmaceutical industry and some conservatives who prefer the free market set competitive prices. But the president has been arguing since 2018 that U.S. senior pays far higher prices because drug makers off-load the development costs on Americans while providing discounts in foreign countries with cost controls. "Americans pay more per capita for prescription drugs than residents of any other developed country in the world," the president's order said. "It is unacceptable that Americans pay more for the exact same drugs, often made in the exact same places. Other countries’ governments regulate drug prices by negotiating with drug manufacturers to secure bargain prices, leaving Americans to make up the difference — effectively subsidizing innovation and lower-cost drugs for the rest of the world."